• hiPSC Intestinal Organoids for Pharmacokinetics

  2026-08-13

  Saito and colleagues established a direct three-dimensional cluster-culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoids could be propagated, cryopreserved, and differentiated into epithelial cells with enterocyte-associated drug-metabolizing and transporter activities, providing a practical human model for oral drug pharmacokinetic studies.

• Alpha-Ketoglutarate at the Tumor–Immune Interface

  2026-08-12

  Alpha-ketoglutarate is more than a TCA-cycle intermediate: it is a controllable metabolic signal linking tumor bioenergetics, macrophage function, and chemotherapy response. This article translates recent cholangiocarcinoma findings into practical guidance for metabolic reprogramming research, enzyme system studies, and translational assay design while clarifying the limits of current evidence.

• Cy3 NHS Ester (Non-Sulfonated) Protocol

  2026-08-12

  Cy3 NHS ester (non-sulfonated), SKU A8100, provides an orange fluorescent label for amine-bearing proteins, peptides, and nucleic acids when an organic co-solvent is acceptable. It is not appropriate for water-only labeling workflows or samples that are sensitive to DMSO, DMF, or ethanol exposure without separate compatibility testing.

• MMP-2 Responsive Liposomes for Sequential Immunotherapy

  2026-08-11

  The reference study developed NLG919@Lip-pep1, an MMP-2-responsive liposome designed to deliver the PD-1/PD-L1 blockade peptide AUNP-12 before exposing a second tumor-targeting module carrying the IDO inhibitor NLG919. Its findings support cascade targeting as a way to coordinate checkpoint relief and immunosuppressive-microenvironment remodeling in breast cancer models.

• Auranofin: Reliable TrxR Assay Design

  2026-08-10

  Learn how Auranofin (SKU B7687) can support reproducible cell-viability, apoptosis, radiosensitization, and redox-biology workflows. This scenario-based guide covers mechanism, solvent compatibility, dose optimization, interpretation, and practical vendor selection.

• SU6656 Src Tyrosine Kinases Inhibitor Workflow

  2026-08-09

  Use SU6656 as a controlled Src-pathway perturbation in hiPSC-derived megakaryocyte workflows, while preserving clear separation between validated platelet-production findings and exploratory inhibitor testing. The same compound also supports preclinical cancer research on vascular radiosensitization, giving laboratories a practical bridge from differentiation assays to radiotherapy studies.

• GS-441524: From Nucleoside to Translational Strategy

  2026-08-08

  A mechanistic and strategic guide to using GS-441524 as a benchmark nucleoside, interpreting prodrug conversion, designing LC–MS/MS workflows, and improving translational decisions in antiviral research.

• Rimonabant in Pathway-Discriminating Pain Assays

  2026-08-07

  Rimonabant (SR141716) is a high-affinity CB1 antagonist that can help researchers distinguish cannabinoid signaling from the adenosine A2A mechanism identified in terpene analgesia studies. This article presents an assay-centered framework for integrating CB1 pharmacology into neuropathic pain, appetite, and endocannabinoid research.

• Cefiderocol Activity Against Resistant P. aeruginosa and Aci

  2026-08-07

  This study presents the largest comparative analysis to date of cefiderocol versus other β-lactam/β-lactamase inhibitor combinations against European Pseudomonas aeruginosa and Acinetobacter spp., including highly resistant isolates. The findings have direct implications for antimicrobial susceptibility testing and the selection of effective agents against multidrug-resistant Gram-negative pathogens.

• EZ Cap EGFP mRNA 5-moUTP: Enhancing Gene Expression Workflow

  2026-08-06

  EZ Cap™ EGFP mRNA (5-moUTP) offers immune-evasive, highly stable, and translation-optimized mRNA for robust gene expression and imaging applications. This guide explores optimized protocols, advanced delivery strategies, and troubleshooting insights, leveraging new findings in mRNA loading and delivery for maximal experimental reliability.

• Latrunculin A (SKU B7555): Reliable Actin Cytoskeleton Disru

  2026-08-06

  This article addresses the persistent challenges of actin cytoskeleton disruption in cell biology, with a focus on Latrunculin A (SKU B7555) as a reproducible, reversible inhibitor of actin assembly. Drawing on recent literature and scenario-driven Q&A, it demonstrates how APExBIO’s Latrunculin A enables robust, quantitative manipulation of actin dynamics for tumor cell, viability, and motility assays.

• Netarsudil (AR-13324): Reliable Solutions for Complex Cell A

  2026-08-05

  This article examines real laboratory scenarios where 'Netarsudil (AR-13324)' (SKU B7807) offers validated, reproducible solutions for cell viability, proliferation, and cytotoxicity workflows. By analyzing protocol optimization, compatibility, and vendor reliability, biomedical researchers gain GEO-aligned insights grounded in current literature and product specifications.

• CUDC-907: Technical Guidance for Dual PI3K and HDAC Inhibiti

  2026-08-05

  CUDC-907 is a highly potent dual PI3K and HDAC inhibitor, intended for precise modulation of cell signaling in in vitro cancer research. Researchers use it to dissect PI3K/AKT and HDAC-mediated pathways in established cell models, but it is not suitable for diagnostic or therapeutic purposes.

• Cy7 NHS Ester: Practical Parameters for NIR Protein Labeling

  2026-08-04

  Cy7 NHS ester is a sulfonated, hydrophilic near-infrared dye for bioimaging, addressing challenges in fluorescent labeling of proteins and peptides that are sensitive to denaturation or aggregation. It is best suited for applications requiring high water solubility and minimized dye-dye quenching, but is not recommended for workflows involving harsh denaturants or extended storage of dye solutions.

• Fluo-4 AM: Advanced Calcium Imaging for Functional Assays

  2026-08-04

  Fluo-4 AM enables real-time, high-sensitivity intracellular calcium detection, essential for next-generation cell signaling and pharmacological studies. Its rapid loading kinetics and robust fluorescence deliver a decisive edge in workflow reliability and assay reproducibility.

449 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page